State Street Corp Kiniksa Pharmaceuticals, Ltd. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.63 - $21.74 $6.04 Million - $7.44 Million	342,448 Added 22.15%	1,888,544 $37.3 Million
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $3.1 Million - $4.11 Million	-215,576 Reduced 12.24%	1,546,096 $27.1 Million
Q3 2023 Nov 14, 2023	BUY	$13.62 - $20.2 $1.49 Million - $2.22 Million	109,701 Added 6.64%	1,761,672 $30.6 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $1.52 Million - $2.4 Million	-145,473 Reduced 8.09%	1,651,971 $23.3 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $3.29 Million - $4.85 Million	307,333 Added 20.62%	1,797,444 $19.3 Million
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $10 Million - $15 Million	878,769 Added 143.74%	1,490,111 $22.3 Million
Q3 2022 Nov 15, 2022	BUY	$9.76 - $13.41 $258,747 - $355,512	26,511 Added 4.53%	611,342 $7.85 Million
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $134,466 - $201,877	17,693 Added 3.12%	584,831 $5.67 Million
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $8.35 Million - $11.1 Million	-898,033 Reduced 61.29%	567,138 $5.64 Million
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $5.91 Million - $8.62 Million	-568,911 Reduced 27.97%	1,465,171 $17.2 Million
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $2.97 Million - $4.23 Million	-260,622 Reduced 11.36%	2,034,082 $23.2 Million
Q2 2021 Aug 16, 2021	BUY	$13.22 - $19.09 $11.6 Million - $16.8 Million	879,922 Added 62.19%	2,294,704 $32 Million
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $2.73 Million - $3.92 Million	-163,730 Reduced 10.37%	1,414,782 $26.2 Million
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $17.2 Million - $24.6 Million	1,164,059 Added 280.87%	1,578,512 $27.9 Million
Q3 2020 Nov 10, 2020	BUY	$15.21 - $25.53 $1.38 Million - $2.31 Million	90,573 Added 27.96%	414,453 $6.35 Million
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $1.52 Million - $2.62 Million	100,650 Added 45.09%	323,880 $8.25 Million
Q1 2020 May 11, 2020	BUY	$11.0 - $19.76 $2.46 Million - $4.41 Million	223,230 New	223,230 $3.46 Million

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.89M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$41.9 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$5.59 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.69 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$1.09 Million
0.0% of portfolio
Barclays PLC London, X0

34.8K
Shares

$961,208
0.0% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $951M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account